ArticlePloS one2025
Rapid risk assessment to address emerging concerns of HPAI in raw and pasteurized milk.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Quantitative Microbial Risk Assessment of Human H5N1 Infection From Consumption of Fluid Cow's Milk.Risk analysis : an official publication of the Society for Risk Analysis · 2026Article
- Quantitative microbial risk assessment of human H5N1 infection from consumption of fluid cow's milk.medRxiv : the preprint server for health sciences · 2026Article
- Risk of infection of dairy cattle in the EU with highly pathogenic avian influenza virus affecting dairy cows in the United States of America (H5N1, Eurasian lineage goose/Guangdong clade 2.3.4.4b. genotype B3.13).EFSA journal. European Food Safety Authority · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
An outbreak of highly pathogenic avian influenza A, subtype H5N1, first reported in U.S. dairy cattle in March 2024, raised concerns of an emerging food safety threat from the virus in the milk supply. To support potential regulatory responses, we conducted a rapid assessment of the predicted risk to U.S. consumers of cow's milk with two complementary and parallel approaches: a "bottom-up" quantitative risk assessment model that integrated data on virus levels in milk, milk consumption, and dose response; and a "top-down" epidemiological analysis that linked current novel flu illness detection to the consumption of raw and pasteurized milk. The dynamic use of the approaches accommodated rapidly evolving data in a range of risk scenarios. The risk assessment model identified pasteurization as a critical control for H5N1 in milk and highlighted the need for i) the targeted sampling of bulk tank raw milk in affected states pre-pasteurization, ii) raw milk herd surveillance and sampling, and iii) a better understanding of ingestion as a route of H5N1 infections for humans. This novel approach and the findings from this study promoted informed decision-making in an evolving outbreak investigation. This methodology can be leveraged in the conduct of future risk assessments to address emerging pathogen outbreaks that impact the food supply.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.